Stefan Huemmer Institutions of which they are part Main researcher Translational Molecular Pathology Vall Hebron Institut de Recerca Email Stefan Huemmer Email Institutions of which they are part Main researcher Translational Molecular Pathology Vall Hebron Institut de Recerca
Projects The MNK inhibitor EB1: a novel opportunity to combat therapy resistance in cancer treatment IP: Santiago Ramon y Cajal Agüeras Collaborators: Inés de Torres Ramirez, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Vicente Peg Camara, Stefan Hummer Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 149347 Reference: 2024 PROD 00056 Duration: 02/12/2024 - 01/06/2026 inhibición de la comunicación celular para la prevención del desarrollo de metástasis y la resistencia a terapias antitumorales. Desarrollo de dos nuevas aproximaciones terapéuticas IP: Santiago Ramon y Cajal Agüeras Collaborators: Maria Rosa Somoza Lopez de Haro, Josep Castellví Vives, Sara Garcia Ortega, Elena Muro Blanc, Marta Cano Galietero, Javier Hernandez Losa, Marta Sese Faustino, Stefan Hummer, Lourdes Elena Salazar Huayna Funding agency: Instituto de Salud Carlos III Funding: 240000 Reference: PI23/01754 Duration: 01/01/2024 - 31/12/2026 Targeting the polyglutamylation enzyme TTLL11 - a novel strategy for cancer therapy (MITOCANCER) IP: Stefan Hummer Collaborators: - Funding agency: Fundació Institut Bioenginyeria de Catalunya Funding: 0.01 Reference: IBEC/2022/ HUMMER Duration: 02/01/2023 - 31/12/2024 MnkImmunOnco) - Overcoming therapy resistance and immune evasion with a novel MNK inhibibtor IP: Santiago Ramon y Cajal Agüeras Collaborators: Inés de Torres Ramirez, Jordi Temprana Salvador, Vicente Peg Camara, Stefan Hummer Funding agency: Fundació Institut Bioenginyeria de Catalunya Funding: 0.01 Reference: M6871 Duration: 02/01/2023 - 31/12/2024 Pagination Current page 1 Page 2 Page 3 Next page › Last page »
